This discrepancy may be attributed to FGF21 resistance and implies that the dysfunctional FGF21–adiponectin axis contributes to the pathogenesis of obesity-related metabolic syndrome [51]. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.